The Retina Foundation of the Southwest is extremely pleased to announce that we have received an anonymous gift of one million dollars to the Retina Foundation of the Southwest to support age-related macular degeneration (AMD) research. This generous gift will be used to help develop new treatments for AMD. At the Retina Foundation, we put […]
READ MOREThe Max and Minnie Tomerlin Voelcker Fund recently gave a $100,000 gift to the Retina Foundation of the Southwest for the Texas 1000 Project, an ambitious project with an overall goal to genotype 1,000 patients with inherited retinal diseases. Determining the genetic mutations causing retinal degenerations such as retinitis pigmentosa, Usher syndrome and Stargardt disease […]
READ MOREEwa Niechwiej-Swedo, Ph.D. from the University of Waterloo in Canada was our speaker for the David R. Stager Sr., M.D. Lecture that was held on Thursday, February 18, 2016. The research of Dr. Niechwiej-Swedo seeks to explain how the brain processes and combines sensory information during goal-directed movements. Specifically, she investigates the role of binocular […]
READ MOREmyVisionTrack®, an iPhone and iPad application developed by researchers at the Retina Foundation of the Southwest to monitor vision for individuals with retinal disease, such as macular degeneration and diabetic retinopathy, has received its second FDA clearance for its new service, the Physician Portal. The app was FDA approved in 2013, but with the new […]
READ MORESince we opened our doors in 1982, the Retina Foundation of the Southwest has been the epicenter of vision research for the southwest region. We have remained steadfast in our mission to advance treatments for vision loss and our accomplishments in research serve as a testament of what we can do, when we work together. […]
READ MORE(Dallas, TX – August 2015) The Retina Foundation of the Southwest and Southern Methodist University Bobby B. Lyle School of Engineering are bringing a new meaning to the term collaboration utilizing an innovation approach that is set apart from any in the United States. The Clinical Center of Innovation for Age-Related Macular Degeneration was established […]
READ MOREFirst-in-human trial of a new gene therapy that seeks to restore sight for patients affected with retinitis pigmentosa (Dallas, Texas – August 25, 2015) The Retina Foundation of the Southwest announced today that it will be the initial site in the nation to conduct a Phase I/II clinical trial to evaluate the efficacy of a […]
READ MORE(Dallas, TX- July 2015) – After the release of promising results from the StemCells, Inc. Phase I/II clinical trial on the safety and efficacy of their proprietary human neural stem cells for the treatment of dry age-related macular degeneration, the Retina Foundation of the Southwest will participate in the expansion of the study as one […]
READ MOREThe Argus II Retinal Prosthesis system uses a tiny camera mounted on what looks like sunglasses, which sends a wireless signal to electrodes implanted on the retina. DALLAS — Relying on a guide to walk down a hallway is just the beginning of Bonnie Harper’s daily challenges with blindness. “Just losing that freedom and doing […]
READ MORE